On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
Experimental compound; the cited studies do not establish an approved thymulin treatment.
Zinc-dependent activity
The human experiments support a relationship between zinc availability and biologically active thymulin, rather than proving a general immune-enhancement effect. [1]
What the evidence shows
Zinc-deficiency study
A 1988 study examined two experimentally zinc-deficient volunteers and small groups with clinical zinc deficiency. Thymulin activity fell with deficiency and recovered with zinc. Participants were not receiving a commercial thymulin injection. [1]
Kidney-disease biomarker study
In nine men on hemodialysis, a six-month zinc study reported increased biologically active thymulin. It evaluated hormone activity in a specific illness, not infection prevention, vaccine protection or anti-aging outcomes. [2]
What remains unknown
The clinical effect of adding exogenous thymulin, rather than correcting a relevant deficiency, is not established by these studies. Reliable long-term safety and interaction data are also lacking.
Safety
Safety cannot be inferred from normal physiology
The small cited zinc studies cannot quantify adverse effects of therapeutic thymulin. An endogenous hormone’s existence does not establish safety of an outside preparation. [1]
Compounded-product uncertainty
Compounded drugs do not receive FDA premarket assessment of their safety, effectiveness and quality. [3]
Study-to-product mismatch
Evidence from oral zinc supplementation cannot validate a thymulin vial, spray or other preparation with different exposure and ingredients. [2]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [4]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [5]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Is thymulin the same as zinc?
No. Zinc is involved in thymulin activity; restoring zinc status and administering thymulin are different interventions.
What would convincing benefit look like?
Controlled studies of the exact preparation measuring meaningful illness outcomes, alongside systematic safety follow-up.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Prasad et al.: zinc and human thymulin activityJournal of Clinical Investigation, 1988; experimental and clinical zinc-deficiency studies, not injected-thymulin treatment.
- Thymulin, zinc and chronic renal failure1989 human investigation of zinc supplementation and thymulin activity in nine men receiving hemodialysis.
- FDA: compounding questions and answersFDA explanation of compounded-drug approval and quality differences; accessed September 9, 2026.
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.